Article

Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and Treatment

2021-12-23

Abstract excerpt

<h4>ABSTRACT</h4> Fcγ RIIA (CD32A) and their ligands, including the immunoglobulin Fc fragment and pentraxins, are key players in a variety of innate immune responses. Still unclear is whether additional ligands of CD32A do exist. The objective of this study is to demonstrate that CD32A-chimeric receptor (CR) can be utilized for the identification of CD32A cell surface ligand(s). Among fifteen cancer cell lines t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69b71b39-b3ce-53fd-8821-a10283801dc8
DOI: 10.1101/2021.12.22.473841

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and TreatmentDOI 10.1101/2021.12.22.473841Read

Construction and characterization of chimeric FcγR T cells for universal T cell therapySemantic proximity Read

Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancerSemantic proximity Read

Macrophages expressing chimeric cytokine receptors have an inflammatory phenotype and anti-tumoral activity upon IL-10 or TGFβ stimulationSemantic proximity Read

A CHIMERIC RECEPTOR ENABLING ANTIBODY-GUIDED RETARGETING OF CAR T- CELLSSemantic proximity Read

Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.Semantic proximity Read

P329G-engager: a universal mix & match antibody-based adaptor platform for cancer immunotherapy.Semantic proximity Read

EGFR as a potent CAR T target in Triple Negative Breast Cancer Brain MetastasesSemantic proximity Read

CD83 Receptor Unveiled as a Therapeutic Target in Metastatic Breast Cancer through Single-Cell RNA-SeqSemantic proximity Read

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical RelevanceSemantic proximity Read

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.Semantic proximity Read

A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasisSemantic proximity Read

Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.Semantic proximity Read